The challenge of hepatitis C in the HIV-infected person

被引：68
作者：
Thomas, David L. [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA
来源：
ANNUAL REVIEW OF MEDICINE | 2008年 / 59卷
关键词：
HCV; coinfection; liver disease; injection drug use;
D O I：
10.1146/annurev.med.59.081906.081110
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Hepatitis C virus (HCV) coinfection occurs in an estimated one quarter of HTV-infected persons in Europe, Australia, and the United States. As use of highly active antiretroviral drugs has markedly reduced opportunistic infections, HCV-related liver disease has emerged as a leading cause of death. HIV infection adversely affects both the natural history and the treatment of hepatitis C. Because there are no experimental models of coinfection and because the pathogenesis of each infection is incompletely understood, how HIV infection alters hepatitis C is not clear. This review considers the epidemiology, natural history, treatment, and pathogenesis of hepatitis C in HIV-infected persons.
引用
收藏
页码：473 / 485
页数：13
相关论文
共 58 条
  • [1] Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV co-infected patients
    Alberti, A
    Clumeck, N
    Collins, S
    Gerlich, W
    Lundgren, J
    Palù, G
    Reiss, P
    Thiebaut, R
    Weiland, O
    Yazdanpanah, Y
    Zeuzem, S
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 (05) : 615 - 624
  • [2] Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons
    Alvarez, D.
    Dieterich, D. T.
    Brau, N.
    Moorehead, L.
    Ball, L.
    Sulkowski, M. S.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2006, 13 (10) : 683 - 689
  • [3] Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes
    Balasubramanian, Anuradha
    Ganju, Ramesh K.
    Groopman, Jerome E.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (05) : 670 - 681
  • [4] Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
    Benhamou, Y
    Bochet, M
    Di Martino, V
    Charlotte, F
    Azria, F
    Coutellier, A
    Vidaud, M
    Bricaire, F
    Opolon, P
    Katlama, C
    Poynard, T
    [J]. HEPATOLOGY, 1999, 30 (04) : 1054 - 1058
  • [5] Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection
    Bica, I
    McGovern, B
    Dhar, R
    Stone, D
    McGowan, K
    Scheib, R
    Snydman, DR
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 (03) : 492 - 497
  • [6] Viral factors associated with cytokine expression during HCV/HIV co-infection
    Blackard, Jason T.
    Kang, Minhee
    St. Clair, J. Benjamin
    Lin, Wenyu
    Kamegaya, Yoshitaka
    Sherman, Kenneth E.
    Koziel, Margaret James
    Peters, Marion G.
    Andersen, Janet
    Chung, Raymond T.
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2007, 27 (04) : 263 - 269
  • [7] Bodsworth NJ, 1996, GENITOURIN MED, V72, P118
  • [8] Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy
    Bräu, N
    Salvatore, M
    Ríos-Bedoya, CF
    Fernández-Carbia, A
    Paronetto, F
    Rodríguez-Orengo, JF
    Rodríguez-Torres, M
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 (01) : 47 - 55
  • [9] Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients -: A randomized controlled trial
    Carrat, F
    Bani-Sadr, F
    Pol, S
    Rosenthal, E
    Lunel-Fabiani, F
    Benzekri, A
    Morand, P
    Goujard, C
    Pialoux, G
    Piroth, L
    Salmon-Céron, D
    Degott, C
    Cacoub, P
    Perronne, C
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (23): : 2839 - 2848
  • [10] Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons
    Chung, RT
    Andersen, J
    Volberding, P
    Robbins, GK
    Liu, T
    Sherman, KE
    Peters, MG
    Koziel, MJ
    Bhan, AK
    Alston, B
    Colquhoun, D
    Nevin, T
    Harb, G
    van der Horst, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05) : 451 - 459
123456